BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 1701948)

  • 1. Mutational analysis of the DNA polymerase and ribonuclease H activities of human immunodeficiency virus type 2 reverse transcriptase expressed in Escherichia coli.
    Hizi A; Tal R; Hughes SH
    Virology; 1991 Jan; 180(1):339-46. PubMed ID: 1701948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational analysis of the ribonuclease H activity of human immunodeficiency virus 1 reverse transcriptase.
    Hizi A; Hughes SH; Shaharabany M
    Virology; 1990 Apr; 175(2):575-80. PubMed ID: 1691564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The DNA-dependent and RNA-dependent DNA polymerase activities of the reverse transcriptases of human immunodeficiency viruses types 1 and 2.
    Shaharabany M; Hizi A
    AIDS Res Hum Retroviruses; 1991 Nov; 7(11):883-8. PubMed ID: 1722105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations within the RNase H domain of human immunodeficiency virus type 1 reverse transcriptase abolish virus infectivity.
    Tisdale M; Schulze T; Larder BA; Moelling K
    J Gen Virol; 1991 Jan; 72 ( Pt 1)():59-66. PubMed ID: 1703563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catalytic properties of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2.
    Hizi A; Tal R; Shaharabany M; Loya S
    J Biol Chem; 1991 Apr; 266(10):6230-9. PubMed ID: 1706712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A large deletion in the connection subdomain of murine leukemia virus reverse transcriptase or replacement of the RNase H domain with Escherichia coli RNase H results in altered polymerase and RNase H activities.
    Post K; Guo J; Kalman E; Uchida T; Crouch RJ; Levin JG
    Biochemistry; 1993 Jun; 32(21):5508-17. PubMed ID: 7684924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of cysteine mutations on the reverse transcriptases of human immunodeficiency virus types 1 and 2.
    Hizi A; Shaharabany M; Tal R; Hughes SH
    J Biol Chem; 1992 Jan; 267(2):1293-7. PubMed ID: 1370463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interaction of illimaquinone, a selective inhibitor of the RNase H activity, with the reverse transcriptases of human immunodeficiency and murine leukemia retroviruses.
    Loya S; Hizi A
    J Biol Chem; 1993 May; 268(13):9323-8. PubMed ID: 7683648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the ribonuclease H activity of HIV-1 reverse transcriptase using RNA.DNA hybrid substrates derived from the gag region of HIV-1.
    Mizrahi V
    Biochemistry; 1989 Nov; 28(23):9088-94. PubMed ID: 2481501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations of a conserved residue within HIV-1 ribonuclease H affect its exo- and endonuclease activities.
    Wöhrl BM; Volkmann S; Moelling K
    J Mol Biol; 1991 Aug; 220(3):801-18. PubMed ID: 1714505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ribonuclease H activity of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2 is modulated by residue 294 of the small subunit.
    Sevilya Z; Loya S; Adir N; Hizi A
    Nucleic Acids Res; 2003 Mar; 31(5):1481-7. PubMed ID: 12595556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The catalytic functions of chimeric reverse transcriptases of human immunodeficiency viruses type 1 and type 2.
    Shaharabany M; Hizi A
    J Biol Chem; 1992 Feb; 267(6):3674-8. PubMed ID: 1371274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reconstitution in vitro of RNase H activity by using purified N-terminal and C-terminal domains of human immunodeficiency virus type 1 reverse transcriptase.
    Hostomsky Z; Hostomska Z; Hudson GO; Moomaw EW; Nodes BR
    Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1148-52. PubMed ID: 1705027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 reverse transcriptase/ribonuclease H: high level expression in Escherichia coli from a plasmid constructed using the polymerase chain reaction.
    D'Aquila RT; Summers WC
    J Acquir Immune Defic Syndr (1988); 1989; 2(6):579-87. PubMed ID: 2479733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural models of ribonuclease H domains in reverse transcriptases from retroviruses.
    Nakamura H; Katayanagi K; Morikawa K; Ikehara M
    Nucleic Acids Res; 1991 Apr; 19(8):1817-23. PubMed ID: 1709492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional analysis of novel selective mutants of the reverse transcriptase of human immunodeficiency virus type 1.
    Hizi A; Shaharabany M
    J Biol Chem; 1992 Sep; 267(26):18255-8. PubMed ID: 1382052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclease activities of Moloney murine leukemia virus reverse transcriptase. Mutants with altered substrate specificities.
    Blain SW; Goff SP
    J Biol Chem; 1993 Nov; 268(31):23585-92. PubMed ID: 7693692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Similarities and differences in the RNase H activities of human immunodeficiency virus type 1 reverse transcriptase and Moloney murine leukemia virus reverse transcriptase.
    Gao HQ; Sarafianos SG; Arnold E; Hughes SH
    J Mol Biol; 1999 Dec; 294(5):1097-113. PubMed ID: 10600369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of cysteine mutations on the catalytic activities of the reverse transcriptase of human immunodeficiency virus type-1.
    Loya S; Tal R; Hughes SH; Hizi A
    J Biol Chem; 1992 Jul; 267(20):13879-83. PubMed ID: 1378433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linker insertion mutagenesis of the human immunodeficiency virus reverse transcriptase expressed in bacteria: definition of the minimal polymerase domain.
    Prasad VR; Goff SP
    Proc Natl Acad Sci U S A; 1989 May; 86(9):3104-8. PubMed ID: 2470090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.